Regenicin, Inc.

RGIN · OTC
Analyze with AI
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Operating Activities
Net Income-$639-$877-$560-$758
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$31
Change in WC$574$818$576$597
Other Non-Cash$38$35-$140$4
Operating Cash Flow-$27-$24-$123-$127
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$40$25$124$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$116
Financing Cash Flow$40$25$124$125
Forex Effect$0$0$0$0
Net Chg. in Cash$13$0$1-$2
Supplemental Information
Beg. Cash$2$1$1$3
End Cash$15$2$1$1
Free Cash Flow-$27-$24-$123-$127